Published in J Diabetes Sci Technol on July 01, 2009
Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas. Annu Rev Control (2012) 1.49
Physical activity and type 1 diabetes: time for a rewire? J Diabetes Sci Technol (2015) 1.00
Physical activity measured by physical activity monitoring system correlates with glucose trends reconstructed from continuous glucose monitoring. Diabetes Technol Ther (2013) 0.90
Role of exercise in the management of diabetes mellitus: the global scenario. PLoS One (2013) 0.86
Blood glucose levels and performance in a sports cAMP for adolescents with type 1 diabetes mellitus: a field study. Int J Pediatr (2010) 0.86
Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy. Diabetes Technol Ther (2013) 0.82
Organic grape juice intake improves functional capillary density and postocclusive reactive hyperemia in triathletes. Clinics (Sao Paulo) (2011) 0.82
Effect of aerobic and anaerobic exercises on glycemic control in type 1 diabetic youths. World J Diabetes (2015) 0.77
Enhanced exercise-induced muscle damage and muscle protein degradation in streptozotocin-induced type 2 diabetic rats. J Diabetes Investig (2011) 0.77
Transcultural diabetes nutrition algorithm: a malaysian application. Int J Endocrinol (2013) 0.76
Accuracy of Continuous Glucose Monitoring (CGM) during Continuous and High-Intensity Interval Exercise in Patients with Type 1 Diabetes Mellitus. Nutrients (2016) 0.75
Influence of ankle fracture surgery on glycemic control in patients with diabetes. BMC Musculoskelet Disord (2016) 0.75
Use of Wearable Sensors and Biometric Variables in an Artificial Pancreas System. Sensors (Basel) (2017) 0.75
The Effect of Acute Hyperglycemia on Muscular Strength, Power and Endurance. Int J Exerc Sci (2017) 0.75
Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. J Diabetes Sci Technol (2015) 0.75
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care (2006) 6.25
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care (2006) 5.20
Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care (2006) 4.52
Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes (2003) 3.90
Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther (2008) 3.82
Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care (2008) 3.66
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care (2007) 3.11
Continuous glucose monitoring in children with type 1 diabetes. J Pediatr (2007) 3.06
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab (2006) 2.35
Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care (2002) 2.18
Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care (2005) 2.11
Use of the noninvasive GlucoWatch Biographer during exercise of varying intensity. Diabetes Technol Ther (2004) 2.11
Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther (2007) 2.10
Barriers to physical activity among patients with type 1 diabetes. Diabetes Care (2008) 2.04
Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther (2006) 1.89
The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther (2005) 1.63
Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes (2002) 1.58
Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther (2008) 1.54
Four grams of glucose. Am J Physiol Endocrinol Metab (2008) 1.37
Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. Diabetes Res Clin Pract (2008) 1.37
Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. Diabetes Metab Res Rev (2004) 1.25
Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technol Ther (2006) 1.18
Physical activity, sport, and pediatric diabetes. Pediatr Diabetes (2006) 1.14
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract (2008) 1.12
The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. Diabetes Res Clin Pract (2008) 1.07
The nuts and bolts of achieving end points with real-time continuous glucose monitoring. Diabetes Care (2008) 1.02
Accuracy of continuous subcutaneous glucose monitoring with the GlucoDay in type 1 diabetic patients treated by subcutaneous insulin infusion during exercise of low versus high intensity. Diabetes Metab (2006) 0.99
Exercise in individuals with IDDM. Diabetes Care (1994) 0.98
New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus: implications for existing guidelines. Sports Med (2007) 0.97
Glucose ingestion and substrate utilization during exercise in boys with IDDM. J Appl Physiol (1985) (2000) 0.92
Type 1 diabetes: exercise and hypoglycemia. Appl Physiol Nutr Metab (2007) 0.91
Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes (2006) 0.91
Monitoring exercise-induced changes in glycemic control in type 2 diabetes. Med Sci Sports Exerc (2006) 0.90
Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects. J Clin Endocrinol Metab (1994) 0.90
Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exerc Sport Sci Rev (2005) 0.89
Glucoregulation during and after intense exercise: effects of alpha-adrenergic blockade. Metabolism (2000) 0.89
Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise. Diabetes (1995) 0.85
Athletes with IDDM exhibit impaired metabolic control and increased lipid utilization with no increase in insulin sensitivity. Diabetes (1995) 0.82
The benefits of continuous glucose monitoring and a glucose monitoring schedule in individuals with type 1 diabetes during recreational diving. J Diabetes Sci Technol (2008) 0.81
The reliability and repeatability of the blood glucose response to prolonged exercise in adolescent boys with IDDM. Diabetes Care (1995) 0.81
Effect of exercise-mediated acidosis on determination of glycemia using CGMS. Diabetes Technol Ther (2006) 0.80
Function of the GlucoWatch G2 Biographer during exercise. Diabetes Technol Ther (2005) 0.80
Substrate source utilization during moderate intensity exercise with glucose ingestion in Type 1 diabetic patients. J Appl Physiol (1985) (2007) 0.78
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med (2010) 8.69
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation (2013) 3.53
Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care (2010) 2.61
Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients? Diabetes Care (2014) 2.29
Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care (2002) 1.99
Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol (2007) 1.92
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus. Cardiovasc Diabetol (2014) 1.75
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study. Diabetes Care (2012) 1.44
Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab (2010) 1.28
Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technol Ther (2006) 1.18
Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes. Diabetes Care (2012) 1.18
Can ultrasound of the tibial nerve detect diabetic peripheral neuropathy? A cross-sectional study. Diabetes Care (2012) 1.17
Structure-function relationship between corneal nerves and conventional small-fiber tests in type 1 diabetes. Diabetes Care (2013) 1.11
Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration. Diabetologia (2014) 1.05
Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care (2011) 1.04
Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care (2009) 1.03
Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care (2012) 1.02
Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract (2008) 0.98
Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters. PLoS One (2013) 0.96
Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care (2004) 0.96
Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study. Diabetes (2011) 0.96
The consequences of anxious temperament for disease detection, self-management behavior, and quality of life in Type 2 diabetes mellitus. J Psychosom Res (2009) 0.93
Conduction slowing in diabetic sensorimotor polyneuropathy. Diabetes Care (2013) 0.92
Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes. Diabetes Care (2012) 0.90
Cystatin C and the risk of death. N Engl J Med (2005) 0.90
Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients. Diabetes Technol Ther (2012) 0.90
Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS One (2012) 0.89
Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia. Diabetes Care (2006) 0.88
Prospective association of 25(OH)D with metabolic syndrome. Clin Endocrinol (Oxf) (2013) 0.87
Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide. J Neurooncol (2015) 0.86
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus. PLoS One (2013) 0.83
How sensitive is the case definition for diabetic sensorimotor polyneuropathy to the use of different symptoms, signs, and nerve conduction parameters in type 1 diabetes? Diabetes Res Clin Pract (2011) 0.82
Diabetes complications and the renin-angiotensin system. N Engl J Med (2009) 0.82
Point accuracy of interstitial continuous glucose monitoring during exercise in type 1 diabetes. Diabetes Technol Ther (2012) 0.82
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care (2013) 0.82
Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP. Expert Rev Clin Immunol (2015) 0.81
Higher magnification lenses versus conventional lenses for evaluation of diabetic neuropathy by corneal in vivo confocal microscopy. Diabetes Res Clin Pract (2012) 0.81
Can improved glycemic control slow renal function decline at all stages of diabetic nephropathy? Semin Nephrol (2012) 0.81
Evaluation of proxy tests for SFSN: evidence for mixed small and large fiber dysfunction. PLoS One (2012) 0.81
The impact of common variation in the definition of diabetic sensorimotor polyneuropathy on the validity of corneal in vivo confocal microscopy in patients with type 1 diabetes: a brief report. J Diabetes Complications (2012) 0.81
White blood cell subtypes, insulin resistance and β-cell dysfunction in high-risk individuals--the PROMISE cohort. Clin Endocrinol (Oxf) (2014) 0.80
Dorsal versus ventral monofilament testing of the great toe for the identification of diabetic sensorimotor polyneuropathy. Diabetes Res Clin Pract (2011) 0.79
Early vascular risk factor modification in type 1 diabetes. N Engl J Med (2005) 0.78
Resistance exercise in type 1 diabetes. Can J Diabetes (2013) 0.78
Intensive therapy and GFR in type 1 diabetes. N Engl J Med (2012) 0.77
Performing resistance exercise before versus after aerobic exercise influences growth hormone secretion in type 1 diabetes. Appl Physiol Nutr Metab (2013) 0.77
Choosing drugs for the treatment of diabetic neuropathy. Expert Opin Pharmacother (2015) 0.76
Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy. Muscle Nerve (2012) 0.75